Related Experiment Videos
Adenosine in myocardial perfusion imaging using positron emission tomography
N C Gupta1, D Esterbrooks, S Mohiuddin
1Department of Radiology, Creighton University Medical Center, Omaha, NE 68131.
American Heart Journal
|July 1, 1991
Summary
Positron emission tomography (PET) assesses myocardial viability by showing metabolic changes from ischemia. Adenosine is a preferred stress agent for PET, especially in acute myocardial infarction patients.
Area of Science:
- Cardiovascular Imaging
- Nuclear Medicine
- Myocardial Viability Assessment
Background:
- Positron emission tomography (PET) is crucial for evaluating myocardial viability by demonstrating metabolic consequences of ischemia.
- PET imaging can identify myocardial segments likely to recover after revascularization.
- PET may offer superior sensitivity and specificity for coronary artery disease detection compared to thallium perfusion imaging.
Purpose of the Study:
- To highlight the value of PET in assessing myocardial viability.
- To compare adenosine with dipyridamole as a pharmacologic stress agent for PET.
- To explore the utility of adenosine-PET in patients post-myocardial infarction.
Main Methods:
- Utilizing positron emission tomography (PET) for myocardial viability assessment.
- Employing adenosine as a pharmacologic stress agent for PET.
- Integrating metabolic studies with PET imaging.
Main Results:
- PET uniquely demonstrates metabolic consequences of myocardial ischemia.
- Adenosine offers advantages over dipyridamole as a PET stress agent, including greater vasodilation and a suitable half-life.
- Adenosine-PET shows potential for assessing patients after acute myocardial infarction.
Conclusions:
- PET is highly valuable for assessing myocardial viability and guiding revascularization decisions.
- Adenosine is a superior pharmacologic stress agent for PET compared to dipyridamole.
- Adenosine-PET, combined with metabolic assessment, is beneficial for post-myocardial infarction patients.